Erratum: Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

被引：0
|
作者：
S Hafeez
A Horwich
O Omar
K Mohammed
A Thompson
P Kumar
V Khoo
N Van As
R Eeles
D Dearnaley
R Huddart
机构：
来源：
British Journal of Cancer | 2016年 / 114卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: British Journal of Cancer (2015) 112, 1626–1635. doi:10.1038/bjc.2015.109; published online 21 April 2015 Updated online 26 May 2016: This article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.
引用
收藏
页码：e24 / e24
相关论文
共 50 条
  • [31] Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response
    Mantovani, G
    Gebbia, V
    Proto, E
    Cossu, F
    Bianchi, A
    Curreli, L
    Ghiani, M
    Massa, E
    Astara, G
    Lampis, B
    Dessi, D
    Santona, MC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (05) : 1035 - 1043
  • [32] Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response
    Mantovani, G
    Curreli, L
    Bianchi, A
    Ghiani, M
    Astara, G
    Lampis, B
    Proto, E
    Cossu, F
    Gebbia, V
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 563 - 567
  • [33] Why consider neoadjuvant chemotherapy for muscle-invasive transitional cell carcinoma of the bladder?
    North, Scott
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2008, 2 (03): : 222 - 224
  • [34] NEO-ADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER-CANCER - EXPERIENCE WITH THE M-VAC REGIMEN
    SCHER, H
    HERR, H
    STERNBERG, C
    FAIR, W
    BOSL, G
    MORSE, M
    SOGANI, P
    WATSON, R
    DERSHAW, D
    REUTER, V
    CURLEY, T
    VAUGHAN, ED
    WHITMORE, W
    YAGODA, A
    BRITISH JOURNAL OF UROLOGY, 1989, 64 (03): : 250 - 256
  • [35] Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Invasive Transitional and Squamous Cell Carcinoma of the Bladder: Effect on Survival and Bladder Preservation
    Khaled, Hussein M.
    Shafik, Hanan E.
    Zabhloul, M. S.
    Ghoneim, M.
    Saber, R. A.
    Manie, M.
    Enein, H. A.
    Megeed, H. A.
    Mansur, O.
    Sherbini, M. E.
    Mahran, T. Z.
    Kalawee, M. E.
    Badran, A.
    Ramadan, Safaa M.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : E233 - E240
  • [36] Role of adjuvant and neoadjuvant chemotherapy in the treatment of transitional-cell carcinoma of bladder cancer
    Cortesi, E
    Caccarelli, F
    Luggini, A
    Nelli, F
    TUMORI JOURNAL, 2001, 87 (04): : S86 - S88
  • [37] INCIDENCE, CHARACTERISTICS, AND IMPLICATIONS OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER UNDERGOING CISPLATIN BASED NEO-ADJUVANT CHEMOTHERAPY
    Patterson, Laurel
    Pandya, Rishikesh
    Margel, David
    Hotte, Sebastien J.
    Shayegan, Bobby
    Mukherjee, Som D.
    Pinthus, Jehonathan H.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E590 - E591
  • [38] Trend in the use of neo-adjuvant chemotherapy for the management of muscle invasive bladder cancer at a major tertiary care hospital in Pakistan.
    Jabbar, Adnan Abdul
    Maqbool, Muhammad Asad
    Mirza, Muhammad Bilal
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Does a Venous Tumor Thrombus Exclude Renal Transitional Cell Carcinoma? Implications for Neo-Adjuvant Treatment Strategies
    Huber, Johannes
    Teber, Dogu
    Hatiboglu, Gencay
    Popeneciu, Valentin
    Jakobi, Hildegard
    Hallscheidt, Peter
    Pahernik, Sascha
    Hohenfellner, Markus
    ANTICANCER RESEARCH, 2014, 34 (02) : 1031 - 1035
  • [40] Treatment results of neo-adjuvant chemotherapy in advanced squamous cell carcinoma of the larynx in Upper Egypt.
    Faris, M
    Saleh, E
    ANNALS OF ONCOLOGY, 2000, 11 : 93 - 93
12345